Androgen Signaling in Prostate Cancer
Charles S. Dai(Harvard University), Nima Sharifi(Sylvester Comprehensive Cancer Center)
Cited by 408
Related Papers
Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer
|eLife|2017|125
Circulating tumor cells: Blood-based detection, molecular biology, and clinical applications
|Cancer Cell|2025|55
TRK inhibitor in a patient with metastatic triple-negative breast cancer and <i>NTRK</i> fusions identified <i>via</i> cell-free DNA analysis
|Therapeutic Advances in Medical Oncology|2023|11
Dynamic Monitoring of Antibody Drug Conjugates Targeting TROP2 or HER2 in Breast Cancer using Circulating Tumor Cells
|bioRxiv (Cold Spring Harbor Laboratory)|2025|3
HSD3B1 upregulation via LRH1 sustains estrogen receptor signaling and promotes endocrine resistance in breast cancer
|Journal of Biological Chemistry|2025|2